– UAE, Dubai – Evercare, a healthcare delivery platform that operates hospitals, clinics and diagnostic facilities across Africa and South Asia, today announced the appointment of Max Colella as CEO, effective January 1, 2020.
Mr. Colella will continue to strengthen Evercare’s leadership position by driving growth and operational excellence at existing facilities, leveraging technology to improve the delivery and cost of healthcare, bringing projects in development to market, and searching for new and complementary investments.
Evercare is wholly owned by The Evercare Health Fund, a $1B emerging markets healthcare fund managed by The Rise Fund, the impact investment platform of global alternative asset manager TPG. The Evercare Health Fund is comprised of the world’s leading development finance institutions and other impact investors.
“There is an urgent need to expand the delivery of affordable high-quality healthcare across the emerging markets. We are excited to have Max joining the Evercare leadership team and believe his extensive expertise in scaling global healthcare businesses will meaningfully advance Evercare’s mission,” said Matthew Hobart, Co-Managing Partner of TPG Growth and head of healthcare investing for The Rise Fund.
About Max Colella
Mr. Colella has over 27 years of experience in the medical device industry. He joins Evercare from Smith & Nephew, a leading medical technology company, where he was President of Europe, Middle East, and Africa, and previously served as Senior Vice President of Asia Pacific and Emerging Markets.
“Throughout my nearly three decades of working in the healthcare industry in Africa, Asia and the Middle East, I have seen first-hand what is needed to build strong healthcare systems in these regions. I look forward to leveraging that experience to help strengthen Evercare’s leadership position, with the ultimate goal of reaching more patients with the highest quality care,” said Mr. Colella.
Prior to that, Mr. Colella spent 21 years at Johnson & Johnson in a number of national and international roles in Europe and Emerging Markets within the Ethicon and DePuy Synthes franchises.
Evercare is an integrated healthcare delivery platform operating in growth markets across Africa and South Asia, including India, Pakistan, Kenya and Nigeria. Evercare helps communities thrive by improving hospital operations and leveraging technology and integration to increase the quality of care. Evercare is building a foundation of continuous quality improvement and standardized care to improve clinical outcomes and patient safety. Evercare’s portfolio includes 27 hospitals, 18 clinics, 45 diagnostics centers and one brownfield asset. Evercare is wholly owned by the Evercare Health Fund, a $1B emerging markets healthcare fund managed by The Rise Fund, the impact investment platform of global alternative asset manager TPG. The Evercare Health Fund is comprised of the world’s leading development finance institutions and other impact investors around the world.
- Disclaimer - News, data and statement included in this release are intended exclusively for general information purposes. Talent4Boards accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the adequacy or accuracy of the information. No data or statement in this release should be considered for decisions about securities referred. Product and brand names used in this release maybe trademarks or registered trademarks of their respective owners.
Comments are closed.